SLRX: Salarius P/S multiplikatori
Tijorat mahsulotlarining yo'qligi Salarius Pharmaceuticals (SLRX) kompaniyasini ventura kapital investitsiyalariga bog'liq qilib qo'ygan. GURU.Markets terminalidagi joriy P/S baholashi ushbu metrika grafigini aks ettiradi, bunda 20.40 qiymati eng so'nggi ko'rsatkichni ifodalaydi. Biznes barqarorligi onkologiyaning nostsiklilik tabiati bilan ta'minlanadi, sinovlar xavfsizligi esa komponentlar tashilishi paytida sovuq zanjirga qat'iy rioya qilinishi bilan kafolatlanadi.
Salarius (SLRX) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- balans bo'yicha xususiy kapital ma'lumotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Barcha qarzlarning o‘z mablag‘lariga nisbati Salarius Pharmaceuticals|SLRX - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti Salarius Pharma|SLRX - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Salarius|SLRX - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz hajmi Salarius Pharmaceuticals|Oraliq qoplash koeffitsiyenti salariuspharma.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
SLRX - Kompaniyaning sof foydasi|Forvard foyda Salarius Pharmaceuticals|SLRX - P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori Salarius Pharmaceuticals Inc|SLRX - PEG multiplikatori|EV/EBITDA multiplikatori Salarius|SLRX - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Salarius Pharmaceuticals|SLRX - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi salariuspharma.com|SLRX - Joriy yilda foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Salarius Pharmaceuticals
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning jamlanma tahliliyoti:SLRX salariuspharma.com
P/S koeffitsiyenti Salarius Pharmaceuticals (SLRX) kompaniyasining bozor kapitalizatsiyasini uning daromadlari bilan bog'laydi va operatsion samaradorlikka nisbatan baholash premiumlarini ochib beradi. Kompaniyaning tarixiy P/S qiymatini tahlil qilish savdo o'sishi yo'qligida kapital korreksiyasi xatarlarini aniqlashga yordam beradi, bu esa onkologiya markazlarida Ewing sarkomasi dori vositalari va qattiq o'smalar terapiyalarining kengayish potentsialini baholash uchun juda muhimdir.
Salarius Pharmaceuticals raqobatchilari
Narx/daromad koeffitsiyenti beigene.com|P/S multiplikatori HALO (Halozyme)|P/S multiplikatori Revolution Medicines Inc RVMD|AAPG - Narxning daromadga nisbati|CGON: Narxning daromadga nisbati|URGN: P/S multiplikatori|bicara.com (BCAX) - P/S multiplikatori|Narxning daromadga nisbati Personalis|ERAS: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori DCTH|Narx/daromad koeffitsiyenti Y-mAbs Corp|Aura Biosciences, Inc. - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Candel Therapeutics Inc. CADL|ARAY - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti SELLAS Life Sciences SLS|ACTU (Actuate Therapeutics, Inc) - Kapitalizatsiyaning daromadga nisbati|Citius Oncology Inc - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati TuHURA Biosciences Inc.|protaratx.com - Narxning sotuvga nisbati|P/S multiplikatori FATE|WHWK (aadibio.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori TCRX (TScan Therapeutics, Inc.)|P/S multiplikatori Champions Oncology Inc CSBR|XBIT - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati CVM (CEL-SCI Corporation)|OS Therapies (OSTX) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati radiopharmtheranostics.com|ARTV (Artiva Biotherapeutics Inc.) - P/S multiplikatori|P/S multiplikatori Adlai Nortye Limited|P/S multiplikatori VERU|Kapitalizatsiyaning daromadga nisbati tempesttx.com TPST|P/S multiplikatori XLO (Xilio Therapeutics)|Renovaro Biosciences (RENB) - Sotuvga nisbatan narx|MURA: Kapitalizatsiyaning daromadga nisbati|KAPA - P/S multiplikatori|OKUR (onkuretherapeutics.com) - Kapitalizatsiyaning daromadga nisbati|GDTC: Kapitalizatsiyaning sotish hajmiga nisbati|CRIS (Curis Inc.) - P/S multiplikatori|Apollomics Corp (APLM) - Narx/daromad koeffitsiyenti|P/S multiplikatori THAR|Kapitalizatsiyaning daromadga nisbati advanbiomed.com ADVB|P/S multiplikatori GNPX (Genprex, Inc.)|P/S multiplikatori Calidi Biotherapeutics Inc. CLDI|SBFM - Narxning daromadga nisbati|XBIO: Narxning daromadga nisbati|Purple Biotech Corp (PPBT) - Narxning daromadga nisbati|AONC - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati BeiGene, Ltd.|checkpointtx.com (CKPT) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Elevation Oncology (ELEV)|Narxning daromadga nisbati ICAD (icadmed.com)|Narxning daromadga nisbati Ikena Oncology IKNA|Bozor kapitallashuvining daromadga nisbati NTBL|VIRX: Kapitalizatsiyaning daromadga nisbati|MOR (morphosys.com) - Kapitalizatsiya va daromad nisbati|NAYA: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Ascentage Pharma Group International
